|1|Radioiodine therapy in patients with Graves' disease and the effects of prior carbimazole therapy. (25285287)
Karyampudi A.... Kamalanathan S.
|2|Left-shifted relation between calcium and parathyroid hormone in Graves' Disease. (24248181)
Annerbo M.... Hellman P.
|3|Maximinus Daia, a Roman emperor who may have had Graves' disease and died of a thyrotoxic crisis. (23624140)
|4|Anaplastic thyroid carcinoma following radioactive iodine therapy for graves' disease. (24396653)
Kim S.H.... Kim S.G.
|5|The negative correlation between thyrotropin receptor-stimulating antibodies and bone mineral density in postmenopausal patients with Graves' disease. (23612147)
Amashukeli M.... Giorgadze E.
|6|Unexpected conversion from hypothyroidism to an euthyroid state due to Graves' disease in a patient with an ectopic thyroid. (24282039)
Szczepanek-Parulska E.... Hernik A.
|7|Mental health status and factors that influence the course of Graves' disease and antithyroid treatments. (23070829)
Chen D.Y.... Chen T.H.
|8|Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine. (21162688)
Bliddal S.... Feldt-Rasmussen U.
|9|Thymic Hyperplasia Associated with Graves' Disease in a 10-year-old Boy. (23926397)
Kawano A.... Kohno H.
|10|Graves' disease. When thyroid hormones run wild. (21200368) |2011|
|11|Serum chemokine (C-X-C motif ) ligand 10 levels are elevated in patients with Graves' disease in long-term remission. (20144041)
Sakai H.... Odawara M.
|12|Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease. (20332709)
Zhu W.... Ning G.
|13|Cancer risk in patients hospitalised for Graves' disease: a population-based cohort study in Sweden. (20354521)
Shu X.... Hemminki K.
|14|The interleukin-1 family gene polymorphisms and Graves' disease. (20400062)
Khalilzadeh O.... Amirzargar A.
|15|Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts. (21124799)
PA8oski R.... Bednarczuk T.
|16|Somatostatin receptor 2 expression determined by immunohistochemistry in cold thyroid nodules exceeds that of hot thyroid nodules, papillary thyroid carcinoma, and Graves' disease. (20450431)
Sancak S.... Paschke R.
|17|Resistance to thyroid hormone in a patient with coexisting Graves' disease. (20151830)
Sivakumar T.... Chaidarun S.
|18|Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T). (20574139)
|19|Familial risks for hospitalized Graves' disease and goiter. (19661127)
Hemminki K.... Sundquist J.
|20|Angiogenic study in Graves' disease treated with thyroid arterial embolization. (19796574)
Zhao W.... Luo G.
|21|Severe ophthalmopathy developing after treatment of coexisting malignant struma ovarii and Graves' disease. (19772400)
Wong L.Y.... Diamond T.H.
|22|High iodine (substrate) turnover Graves' disease: the intriguing 'rapid responder' variant of thyrotoxicosis. (18941129)
Dalan R.... Ng D.C.
|23|Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease. (18449200)
Zeitlin A.A.... Simmonds M.J.
|24|Association of tumour necrosis factor alpha (TNF-alpha) polymorphisms with Graves' disease: A meta-analysis. (18472000)
Li N.... Chen X.
|25|B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis. (18832736)
Douglas R.S.... Smith T.J.
|26|The adaptation and relationship of FGF-23 to changes in mineral metabolism in Graves' disease. (17437520)
Park S.E.... Lim S.K.
|27|Correlation between serum osteoprotegerin and biomarkers of bone metabolism during anti-thyroid treatment in patients with Graves' disease. (16912510)
Mochizuki Y.... Monden T.
|28|Elephantiasis Nostras Verrucosa: a rare thyroid dermopathy in Graves' disease. (16121817)
Kakati S.... Deka U.J.
|29|A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population. (15956353)
Jennings C.E.... Pearce S.H.
|30|Gray-scale and color Doppler sonographic findings in a case of mesenteric Castleman's disease incidentally detected in a patient with Graves' disease. (16196012)
Loy M.... Stefano M.
|31|Pretibial myxedema, ophthalmopathy and acropachy in a male patient with Graves' disease. (17642674)
Veeranna S.... Savitha .
|32|Reversible mitral valve prolapse and mitral regurgitation in children with Graves' disease. (15506680)
Liu Y.P.... Wu M.H.
|33|Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. (11836263)
Schwartz K.M.... Pond G.R.
|34|Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. (11380496)
Noh J.Y.... Ito K.
|35|Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. (11014313)
Rapoport B.... McLachlan S.M.
|36|An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease. (10946880)
Yamada T.... Tanaka Y.
|37|Thyroid-associated ophthalmopathy in black South African patients with Graves' disease: relationship to antiflavoprotein antibodies. (9848717)
Joffe B.... Wall J.R.
|38|Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis. (9545110)
Hidaka Y.... Amino N.
|39|CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. (9459626)
Yanagawa T.... Saruta T.
|40|CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. (8989248)
Donner H.... Badenhoop K.
|41|Expression of membrane and soluble intercellular adhesion molecule-1 in Graves' disease. (9343311)
Massart C.... Maugendre D.
|42|Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies. (8636291)
Morgenthaler N.G.... Banga J.P.
|43|Systemic scleroderma associated with Graves' disease. (9037923)
Anzai H.... Tajima S.
|44|CD31, CD62E, and CD62P identify a specific pattern of endothelial activation in Graves' disease. (7542186)
Aubert V.D.... Faure G.C.
|45|Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines. (7615799)
Mullins R.J.... Feldmann M.
|46|A case of pretibial myxedema associated with Graves' disease: an immunohistochemical study of serum-derived hyaluronan-associated protein. (8648004)
Shishido M.... Shinkai H.
|47|Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease. (7866729)
BalA!zs C.... Kiss E.
|48|Dynamic changes in soluble interleukin-2 receptor levels during treatment of Graves' disease. Correlation with disease activity. (1916654)
Weryha G.... Hartemann P.
|49|Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis. (2567295)
Ito M.... Saito H.
|50|Ultrastructural and immunological findings in Graves' disease with pretibial myxedema. (6989863)
Konrad K.... Pehamberger H.